Print Friendly
Kelly L. Sullivan, Ph.D.

Assistant Professor
Co-Director, USF Ataxia Research Center

12901 Bruce B. Downs Blvd
Tampa, FL 33612

Phone: (813) 974-5335
Fax: (813) 974-8032
Email: kbarber@health.usf.edu

Kelly L. Sullivan, Ph.D. 




Graduate School: University of South Florida
College of Public Health
Epidemiology and Biostatistics

Research Interests

My research examines risk factors for neurologic conditions and evaluates potential new treatments for these conditions. I have over 10 years of experience in the design, management and analysis of studies for conditions including tremor, Parkinson’s disease, and ataxia. In addition, I serve on the Guideline Development Subcommittee for the American Academy of Neurology to develop evidence based guidelines.


  • American Academy of Neurology (AAN)
  • AAN Movement Disorders Section
  • AAN Neuroepidemiology Section
  • World Federation of Neurology, Neuroepidemiology Section
  • Movement Disorder Society (MDS)
  • Society for Epidemiologic Research

Selected Publications

  1. Sullivan KL, Hauser RA, Zesiewicz TA. Essential Tremor: A Review. The Neurologist 2004, 10(5):250-258.
  2. Zesiewicz TA, Strom JA, Borenstein AR, Hauser RA, Cimino CR, Fontanet H, Cintron C, Staffetti JF, Dunne PB, Sullivan KL. Heart Failure in Parkinson’s Disease: Analysis of the United States Medicare Current Beneficiary Survey, 1997-1999. Parkinsonism & Related Disorders, 10(7):417-420.
  3. Sullivan KL, Staffetti JF, Hauser RA, Dunne PB, Zesiewicz TA. Tegaserod (Zelnorm) for the Treatment of Constipation in Parkinson’s Disease. Mov Disord 2006;21(1):115-116.
  4. Zesiewicz TA, Wecker L, Sullivan KL, Merlin LR, Hauser RA. The Controversy Concerning Plasma Homocysteine in Parkinson’s Disease Patients Treated with Levodopa alone or with Entacapone: Effects of Vitamin Status. Journal of Clinical Neuropharmacology, 2006 May-Jun;29(3):106-11.
  5. Sullivan KL, Ward CL, Hauser RA, Zesiewicz TA. Prevalence and Treatment of Non-Motor Symptoms in Parkinson's Disease. Parkinsonism Relat Disord. 2007 Dec;13(8):545.
  6. Zesiewicz TA, Sullivan KL, Arnulf I, Chaudhuri KR, Morgan JC, Gronseth GS, Miyasaki J, Iverson DJ, Weiner WJ; Quality Standards Subcommittee of the American Academy of Neurology. Practice Parameter: treatment of nonmotor symptoms of Parkinson disease: report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology. 2010;74(11):924-31.
  7. Zesiewicz TA, Greenstein PE, Sullivan KL, Wecker L, Miller A, Jahan I, Chen R, Perlman SL. A Randomized Trial of Varenicline (Chantix) for the Treatment of Spinocerebellar Ataxia Type 3. Neurology. 2012;78(8):545-550.